Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Natan Ponieman

Irwin Naturals Passes $100M In Yearly Revenue On Earnings Call, Continues Expansion Into Ketamine And CBD

Irwin Naturals Inc. (CSE:IWIN) (OTC:IWINF) released financial results for the fiscal fourth quarter and the financial year ended December 31, 2021.

The company, active in the natural supplements market since 1994, added CBD products in 2018 and this year entered the psychedelics space with the purchase of several mental health clinics providing Ketamine treatment.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.